J&J takes $110M hit in talc trial

|By:, SA News Editor

Adding to a string of losses, Johnson & Johnson (NYSE:JNJ) has been ordered to pay over $110M to a Virginia woman who said she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.

The Missouri jury verdict was the largest so far to arise out of about 2,400 lawsuits accusing J&J of not adequately warning consumers about cancer risks.